Skip to main content
Log in

Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes

  • Correspondence
  • Published:

From Nature Genetics

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Guo, D. et al. Nat. Genet. 36, 837–841 (2004).

    Article  CAS  Google Scholar 

  2. Bohren, K.M., Nadkarni, V., Song, J.H., Gabbay, K.H. & Owerbach, D. J. Biol. Chem. 279, 27233–27238 (2004).

    Article  CAS  Google Scholar 

  3. The International HapMap Consortium. Nature 426, 789–796 (2003).

  4. Horvath, S., Xu, X. & Laird, N.M. Eur. J. Hum. Genet. 9, 301–306 (2001).

    Article  CAS  Google Scholar 

  5. Newhook, L.A. et al. Diabetes Care 27, 885–888 (2004).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Constantin Polychronakos.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qu, H., Bharaj, B., Liu, XQ. et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 37, 111–112 (2005). https://doi.org/10.1038/ng0205-111

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0205-111

  • Springer Nature America, Inc.

This article is cited by

Navigation